Consensus Target
High Target
Median Target
Low Target
| Date | Analyst | Company | Price Target | News Title |
|---|---|---|---|---|
| 2026-01-07 | N/A | Jefferies | $31 | Monte Rosa Therapeutics price target raised to $31 from $22 at Jefferies |
| 2026-01-07 | N/A | Wedbush | $37 | Monte Rosa Therapeutics price target raised to $37 from $26 at Wedbush |
| 2025-12-17 | Kelly Shi | Jefferies | $22 | Monte Rosa Therapeutics (GLUE) PT Raised to $22 at Jefferies |
| 2025-12-16 | N/A | Wells Fargo | $22 | Monte Rosa Therapeutics upgraded to Overweight from Equal Weight at Wells Fargo |